Anxiety and Depression in Epilepsy: A Pilot Treatment Study
Status:
Withdrawn
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
As a potential solution to address high rates of depression and anxiety seen in epilepsy
patients and poor mental health care access, this trial aims to carry out treatment for
depression and anxiety directly in the epilepsy clinic. Patients that meet eligibility
criteria, including significant symptoms of depression and/or anxiety, will be enrolled in
the intervention. The intervention will consist of an initial prescription for an
FDA-approved medication to treat depression/anxiety and telephone-based chronic care
management plan for repeated symptom measurement and side effect surveillance. The purpose of
this pre-piloting limited study is to streamline recruitment, intervention and outcome
assessment process in preparation for a randomized, controlled pilot of the intervention.